SelectScienceIndustry News: Big Step Forward for Novartis CAR-T Cancer Therapy after FDA BackingSelectScienceNovartis recently announced a unanimous recommendation of their CAR-T cell therapy CTL019 by the US Food and Drug Administration (FDA) Oncologi… Continue reading
SelectScienceIndustry News: Big Step Forward for Novartis CAR-T Cancer Therapy after FDA BackingSelectScienceNovartis recently announced a unanimous recommendation of their CAR-T cell therapy CTL019 by the US Food and Drug Administration (FDA) Oncologi… Continue reading
Reuters |
AstraZeneca a tricky takeover target after big cancer drug blow
Reuters Two other new cancer medicines, Tagrisso and Lynparza, are doing well, while its troubled immunotherapy drug Imfinzi should still be a significant seller for non-metastatic lung cancer, despite the big hit to the firm’s chances in advanced disease. BMS takes AstraZeneca to court over cancer treatmentLife Sciences Intellectual Property Review (subscription) |
|
Isogenica Announces New Licence Agreement with Takeda
Business Wire (press release) Isogenica is a synthetic biology company focusing on the design and build of diverse antibody libraries for use in biopharmaceuticals. Partners can access an advanced camelid single-domain antibody library (llamdA™) and state-of-the-art, fully … |
|
If you could ‘design’ your own child, would you?
New Zealand Herald But supporters of synthetic biology talk up huge potential long-term benefits. We could, they claim, potentially edit genes and build new ones to eradicate all hereditary diseases. With genetic alterations, we might be able to withstand anthrax attacks … |
|
If you could ‘design’ your own child, would you?
New Zealand Herald But supporters of synthetic biology talk up huge potential long-term benefits. We could, they claim, potentially edit genes and build new ones to eradicate all hereditary diseases. With genetic alterations, we might be able to withstand anthrax attacks … |
UC Berkeley |
How Powerful is CRISPR?
Newswise (press release) Newswise — “Good morning, doctor, I am here for my gene editing appointment.” In the future, could this be a greeting heard in physician offices around the world? With the introduction of CRISPR technology, genetic material can now be more easily and … Aug. 16-17 CRISPRcon to focus on societal issues of gene editingUC Berkeley |